Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London

February 11, 2013 3:19 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES , Feb. 11, 2013 /- NeuroSigma, Inc., a California -based medical device company, today announced that Christopher DeGiorgio , M.D., Vice President of Neurology at NeuroSigma and Professor of Neurology at the University of California, Los Angeles (UCLA), and Colin Kealey , M.D., Manager of Business Development at NeuroSigma, will present in London , an over...

TOPICS:

The AcessaT System Now Approved In Mexico To Treat Symptomatic Uterine Fibroids

February 11, 2013 3:00 am | by The Associated Press | News | Comments

Halt Medical, Inc. announced today that on January 18, 2013, COFEPRIS, a division within the Mexican Ministry of Health (Secretaria de Salud) responsible for medical device oversight, issued registration for the Acessa System to treat symptomatic uterine fibroids. "Mexico is the second...

TOPICS:

Vexim Accelerates Its European Development by Establishing a Subsidiary in the UK

February 11, 2013 2:00 am | by The Associated Press | News | Comments

TOULOUSE, France--(BUSINESS WIRE)--Feb 11, 2013--Regulatory News: Vexim (Paris:ALVXM) (FR0011072602 – ALVXM), a medical device company specializing in minimally invasive treatment of vertebral fractures, today announces the establishment of a new subsidiary, VEXIM UK Ltd that will enable the...

TOPICS:
Advertisement

Biolase Expands Soft-Tissue Laser to New Markets

February 8, 2013 9:59 pm | by Mass Device | News | Comments

Biolase wins a nod from the FDA to expand its soft-tissue laser to 19 different markets. Biolase (NSDQ:BIOL) won FDA approval for the use of its 940nm Diolase 10 laser in a range of different markets. The federal watchdog agency also cleared 80 new procedures for the device. The Irvine, Ca-based dental laser company said it can now sell into more than 20 new markets, including ear, nose and throat...

TOPICS:

Zoll Lands FDA Clearance for Automated External Defibrillator

February 8, 2013 3:27 pm | by Mass Device | News | Comments

Zoll Medical wins 510(k) clearance for its AED Plus CPR-assist technology. Asahi Kasei (TYO:3407) subsidiary Zoll Medical won 510(k) clearance from the FDA for its fully-automated AED Plus device, which improves on the former semi-automatic model. The new automated external defibrillator allows emergency responders to pre-program a shock instead of pushing the "shock" button.

TOPICS:

FDA Seeks Comment on Device Detention Rules

February 8, 2013 3:20 pm | by Mass Device | News | Comments

The FDA proposes to renew the inspection protocols for banned medical devices and is seeking more - make that any - comment from the public. Having pursued less than 1 device detention annually over the past several years, the FDA is proposing once again to extend and renew the program that collects information about medical devices, submitting the proposed changes to the Office of Management & Budget for approval.

TOPICS:

St. Jude Revisits RESPECT Trial, Touts Signs of Benefits of Amplatzer Device

February 8, 2013 3:18 pm | by Mass Device | News | Comments

St. Jude Medical touts new findings from its failed RESPECT trial, reporting that the Amplatzer PFO closure device demonstrated benefits over drug therapy alone. Medical device giant St. Jude Medical (NYSE:STJ) resurrected data from its failed RESPECT study, touting additional analyses and benefits of its Amplatzer patent foramen ovale closure device.

TOPICS:

Supreme Court Denies Retractable Technologies in Patent War with BD

February 8, 2013 3:08 pm | by Mass Device | News | Comments

The Supremes last month refused to hear an appeal of a lower court's decision to overturn part of Retractable's win over BD, which the Little Elm, Texas-based medical device company sued in June 2007, claiming that Becton's Integra syringes infringe patents covering its competing VanishPoint devices.

TOPICS:
Advertisement

Ellsworth Adhesives Acquires Adhesive Methods and Technology

February 8, 2013 2:25 pm | by Ellsworth Adhesives | Ellsworth Adhesives | News | Comments

Ellsworth Adhesives, the world’s largest distributor of adhesive products and dispensing equipment, announced today that it has acquired Tennessee-based distributor, Adhesive Methods and Technology (AMT). With operations based in Memphis, TN, Adhesive Methods and Technology specializes in industrial adhesives and dispensing equipment.

Pitt/UPMC Team Describes Technology that Lets Spinal Cord-Injured Man Control Robot Arm with Thoughts

February 8, 2013 1:44 pm | by University of Pittsburgh School of Medicine | News | Comments

Researchers at the University of Pittsburgh School of Medicine and UPMC describe in PLoS ONE how an electrode array sitting on top of the brain enabled a 30-year-old paralyzed man to control the movement of a character on a computer screen in three dimensions with just his thoughts. It also enabled him to move a robot arm to touch a friend’s hand for the first time in the seven years.

TOPICS:

TorkLaw Responds to FDA Warning Letter to St. Jude Medical Regarding Defective Heart Device; Now Representing Patients in 15 States

February 8, 2013 1:32 pm | by Bio-Medicine.Org | News | Comments

LOS ANGELES , Feb. 9, 2013 /- Product liability law firm TorkLaw continues to pursue litigation against St. Jude Medical on behalf of injured patients and their families. In December 2011, the Food and Drug Administration issued a Class 1 recall for the St. Jude Medical Riata leads after many adverse events were being reported in patients. Studies showed that t...

TOPICS:

Galen Partners and International Business Forum Announce Details for Inaugural Healthcare Growth Capital Conference

February 8, 2013 9:00 am | by The Associated Press | News | Comments

STAMFORD, Conn.--(BUSINESS WIRE)--Feb 8, 2013--The inaugural Healthcare Growth Capital Conference will be held on April 11 th, 2013, at the W Hotel in New York City. The conference is being co-sponsored by Galen Partners, a leading growth equity firm focused solely on the healthcare industry, and...

Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013

February 8, 2013 8:00 am | by The Associated Press | News | Comments

ST. PAUL, Minn.--(BUSINESS WIRE)--Feb 8, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the presentation of additional data from its landmark RESPECT trial at the American Stroke Association’s International Stroke Conference 2013 in Honolulu. The RESPECT...

TOPICS:

IBM Watson Hard At Work: New Breakthroughs Transform Quality Care for Patients

February 8, 2013 12:30 am | by IBM | News | Comments

IBM, WellPoint, Inc. and Memorial Sloan-Kettering Cancer Center today unveiled the first commercially developed Watson-based cognitive computing breakthroughs. These innovations stand alone to help transform the quality and speed of care delivered to patients through individualized, evidence based medicine.

TOPICS:

Two-Year Clinical Study Supports Safety and Efficacy of Covidien Revascularization Device

February 7, 2013 6:42 pm | by The Associated Press | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Feb 7, 2013--Covidien (NYSE:COV), a leading global provider of healthcare products, today released the results of the Solitaire™ FR Thrombectomy for Acute Revascularization (STAR) study. The two-year study evaluated the safety and efficacy of the Solitaire FR...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading